|
Volumn 6, Issue 7, 2003, Pages 652-655
|
Pain Therapeutics - SMi Conference 11-12 June 2003, London, UK
|
Author keywords
[No Author keywords available]
|
Indexed keywords
6 (4 CARBOXYBENZYL) 1,2,3,4,4A,5,6,7,8,8A DECAHYDRO 3 ISOQUINOLINECARBOXYLIC ACID;
ANALGESIC AGENT;
ANESTHETIC AGENT;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANTIMIGRAINE AGENT;
BIBN 4096;
CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST;
CANNABIDIOL;
CANNABINOID;
CANNABIS;
CAPSAICIN;
CIGARETTE SMOKE;
DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID;
DILECTAN;
GW 1000;
IN TRIPTAN;
IX 1003;
IX 2000;
IX 2100;
IX 3000;
LIDOCAINE;
LY 435735;
NGX 4010;
OLCEGEPANT;
OMEGA CONOTOXIN MVIIA;
OPIATE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
SUMATRIPTAN;
SUMATRIPTAN SUCCINATE;
SYN 1002;
TETRAHYDROCANNABINOL;
TETRAHYDROCANNABINOL PLUS CANNABIDIOL;
TRANSDOLOR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ZOLMITRIPTAN;
AREA UNDER THE CURVE;
BRACHIAL PLEXUS INJURY;
BURNING SENSATION;
CARDIOVASCULAR DISEASE;
CENTRAL NERVOUS SYSTEM DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG ACCUMULATION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG COST;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG MEGADOSE;
DRUG METABOLISM;
DRUG RESEARCH;
DRUG STRUCTURE;
DRUNKENNESS;
DYSGEUSIA;
ECONOMIC ASPECT;
ERYTHEMA;
HUMAN;
INHIBITION KINETICS;
JOB PERFORMANCE;
MIGRAINE;
MULTIPLE SCLEROSIS;
NEUROPATHIC PAIN;
NONHUMAN;
ORGANIZATION;
PAIN;
POSTHERPETIC NEURALGIA;
SIDE EFFECT;
SKIN MANIFESTATION;
SOMNOLENCE;
TRANSDERMAL PATCH;
TREATMENT PLANNING;
VERTIGO;
ANALGESICS;
ANALGESICS, OPIOID;
CANNABINOIDS;
CLINICAL TRIALS;
HUMANS;
MOLECULAR STRUCTURE;
PAIN;
|
EID: 0041664079
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|